[{"notes_id":"1_1028","category":"8","subcategory":"0","title":"Tamoxifen","body":"Tamoxifen is a <span class=\"concept\" data-cid=\"8854\">Selective oEstrogen Receptor Modulator (SERM)<\/span> which acts as an oestrogen receptor antagonist and partial agonist. It is used in the management of oestrogen receptor positive breast cancer<br \/><br \/>Adverse effects<br \/><ul><li>menstrual disturbance: vaginal bleeding, amenorrhoea<\/li><li>hot <span class=\"concept\" data-cid=\"8855\">flushes<\/span> - 3% of patients stop taking tamoxifen due to climacteric side-effects<\/li><li><span class=\"concept\" data-cid=\"2847\">venous thromboembolism<\/span><\/li><li><span class=\"concept\" data-cid=\"8856\">endometrial cancer<\/span><\/li><\/ul> <br \/>Tamoxifen is typically used for 5 years following removal of the tumour.<br \/><br \/>Raloxifene is a pure oestrogen receptor antagonist, and carries a lower risk of endometrial cancer","notes_hash":"51288bd8478c1125c910744557af4b2f","knowledge_graph_node_id_link":0,"links":"<table style='width:100%'><tr><td>BNF<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_303\" data-linkid=\"303\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_303\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">14<\/span><button type=\"button\" style=\"\" id=\"link_dislike_303\" data-linkid=\"303\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_303\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">3<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/bnf.nice.org.uk\/drug\/tamoxifen.html\">Tamoxifen<\/a><\/td><\/tr><\/table>","media":"","concepts_for_notes":{"2847":{"concept_text":"Tamoxifen therapy increases the risk of venous thromboembolism","concept_percentile":"52"},"8854":{"concept_text":"Tamoxifen - selective oestrogen receptor modulator","concept_percentile":"22"},"8855":{"concept_text":"Tamoxifen may cause hot flushes","concept_percentile":"41"},"8856":{"concept_text":"Tamoxifen may cause increased risk of endometrial cancer","concept_percentile":"15"}},"category_name":"Pharmacology and therapeutics","subcategory_name":"","comment_count":2},"",[]]